For example, active phospho-ATM is co-localised with the hypoxic marker CAIX in tumour xenografts [74] and RAD51 down-regulation was observed in cervical and prostate cancer xenografts [61] as well as in a glioma model [75]. This evidence concerns the gene CA9 and glioma.